Bill Text: TX HB49 | 2011-2012 | 82nd Legislature | Introduced
Bill Title: Relating to the addition of certain synthetic derivatives of marihuana to Penalty Group 2 of the Texas Controlled Substances Act.
Sponsorship: Partisan Bill (Democrat 1)
Status: (Introduced - Dead) 2011-03-22 - Left pending in committee [HB49 Detail]
Download: Texas-2011-HB49-Introduced.html
| 82R829 JSC-F | ||
| By: Peña | H.B. No. 49 | |
|
|
||
|
|
||
| relating to the addition of certain synthetic derivatives of | ||
| marihuana to Penalty Group 2 of the Texas Controlled Substances | ||
| Act. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Section 481.103(a), Health and Safety Code, is | ||
| amended to read as follows: | ||
| (a) Penalty Group 2 consists of: | ||
| (1) any quantity of the following hallucinogenic | ||
| substances, their salts, isomers, and salts of isomers, unless | ||
| specifically excepted, if the existence of these salts, isomers, | ||
| and salts of isomers is possible within the specific chemical | ||
| designation: | ||
| alpha-ethyltryptamine; | ||
| alpha-methyltryptamine; | ||
| 4-bromo-2, 5-dimethoxyamphetamine (some trade or | ||
| other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine; | ||
| 4-bromo-2, 5-DMA); | ||
| 4-bromo-2, 5-dimethoxyphenethylamine; | ||
| Bufotenine (some trade and other names: 3-(beta- | ||
| Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- | ||
| indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- | ||
| dimethyltryptamine; mappine); | ||
| Diethyltryptamine (some trade and other names: N, | ||
| N-Diethyltryptamine, DET); | ||
| 2, 5-dimethoxyamphetamine (some trade or other | ||
| names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); | ||
| 2, 5-dimethoxy-4-ethylamphetamine (trade or other | ||
| name: DOET); | ||
| 2, 5-dimethoxy-4-(n)-propylthiophenethylamine | ||
| (trade or other name: 2C-T-7); | ||
| Dimethyltryptamine (trade or other name: DMT); | ||
| Dronabinol (synthetic) in sesame oil and | ||
| encapsulated in a soft gelatin capsule in a U.S. Food and Drug | ||
| Administration approved drug product (some trade or other names for | ||
| Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- | ||
| trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- | ||
| (trans)- tetrahydrocannabinol); | ||
| Ethylamine Analog of Phencyclidine (some trade or | ||
| other names: N-ethyl-1-phenylcyclohexylamine, (1- | ||
| phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, | ||
| cyclohexamine, PCE); | ||
| Ibogaine (some trade or other names: 7-Ethyl-6, 6, | ||
| beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- | ||
| pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); | ||
| Mescaline; | ||
| 5-methoxy-N, N-diisopropyltryptamine; | ||
| 5-methoxy-3, 4-methylenedioxy amphetamine; | ||
| 4-methoxyamphetamine (some trade or other names: | ||
| 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; | ||
| PMA); | ||
| 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, | ||
| PPMP); | ||
| 4-methyl-2, 5-dimethoxyamphetamine (some trade | ||
| and other names: 4-methyl-2, 5-dimethoxy-alpha- | ||
| methylphenethylamine; "DOM"; "STP"); | ||
| 3,4-methylenedioxy methamphetamine (MDMA, MDM); | ||
| 3,4-methylenedioxy amphetamine; | ||
| 3,4-methylenedioxy N-ethylamphetamine (Also | ||
| known as N-ethyl MDA); | ||
| Nabilone (Another name for nabilone: (+)-trans- | ||
| 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, | ||
| 6-dimethyl-9H-dibenzo[b,d] pyran-9-one; | ||
| N-benzylpiperazine (some trade or other names: | ||
| BZP; 1-benzylpiperazine); | ||
| N-ethyl-3-piperidyl benzilate; | ||
| N-hydroxy-3,4-methylenedioxyamphetamine (Also | ||
| known as N-hydroxy MDA); | ||
| 4-methylaminorex; | ||
| N-methyl-3-piperidyl benzilate; | ||
| Parahexyl (some trade or other names: 3-Hexyl-1- | ||
| hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] | ||
| pyran; Synhexyl); | ||
| 1-Phenylcyclohexylamine; | ||
| 1-Piperidinocyclohexanecarbonitrile (PCC); | ||
| Psilocin; | ||
| Psilocybin; | ||
| Pyrrolidine Analog of Phencyclidine (some trade | ||
| or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); | ||
| Synthetic cannabinoids that are structurally and | ||
| clinically similar to marihuana and their analogues and homologues, | ||
| such as: | ||
| Dexanabinol, | ||
| (6aS,10aS)-9-(hydroxymethyl)-6, | ||
| 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] | ||
| chromen-1-ol; | ||
| Indole, or 1-butyl-3(1-naphthoyl)indole; | ||
| Indole, or 1-pentyl-3(1-naphthoyl)indole; | ||
| Phenol, CP 47, 497 and homologues, or | ||
| 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), | ||
| where side chain n=5, and homologues where side chain n-4,6, or 7; | ||
| Tetrahydrocannabinols, other than marihuana, and | ||
| synthetic equivalents of the substances contained in the plant, or | ||
| in the resinous extractives of Cannabis, or synthetic substances, | ||
| derivatives, and their isomers with similar chemical structure and | ||
| pharmacological activity such as: | ||
| delta-1 cis or trans tetrahydrocannabinol, | ||
| and their optical isomers; | ||
| delta-6 cis or trans tetrahydrocannabinol, | ||
| and their optical isomers; | ||
| delta-3, 4 cis or trans | ||
| tetrahydrocannabinol, and its optical isomers; | ||
| compounds of these structures, regardless of | ||
| numerical designation of atomic positions, since nomenclature of | ||
| these substances is not internationally standardized; | ||
| Thiophene Analog of Phencyclidine (some trade or | ||
| other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl | ||
| Analog of Phencyclidine; TPCP, TCP); | ||
| 1-pyrrolidine (some trade or other name: TCPy); | ||
| 1-(3-trifluoromethylphenyl)piperazine (trade or | ||
| other name: TFMPP); and | ||
| 3,4,5-trimethoxy amphetamine; | ||
| (2) Phenylacetone (some trade or other names: | ||
| Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl | ||
| ketone); and | ||
| (3) unless specifically excepted or unless listed in | ||
| another Penalty Group, a material, compound, mixture, or | ||
| preparation that contains any quantity of the following substances | ||
| having a potential for abuse associated with a depressant or | ||
| stimulant effect on the central nervous system: | ||
| Aminorex (some trade or other names: aminoxaphen; | ||
| 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- | ||
| phenyl-2-oxazolamine); | ||
| Amphetamine, its salts, optical isomers, and | ||
| salts of optical isomers; | ||
| Cathinone (some trade or other names: 2-amino-1- | ||
| phenyl-1-propanone, alpha-aminopropiophenone, 2- | ||
| aminopropiophenone); | ||
| Etorphine Hydrochloride; | ||
| Fenethylline and its salts; | ||
| Lisdexamfetamine, including its salts, isomers, | ||
| and salts of isomers; | ||
| Mecloqualone and its salts; | ||
| Methaqualone and its salts; | ||
| Methcathinone (some trade or other names: 2- | ||
| methylamino-propiophenone; alpha-(methylamino)propriophenone; | ||
| 2-(methylamino)-1-phenylpropan-1-one; alpha-N- | ||
| methylaminopropriophenone; monomethylpropion; ephedrone, N- | ||
| methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR | ||
| 1431); | ||
| N-Ethylamphetamine, its salts, optical isomers, | ||
| and salts of optical isomers; and | ||
| N,N-dimethylamphetamine (some trade or other | ||
| names: N,N,alpha-trimethylbenzeneethaneamine; | ||
| N,N,alpha-trimethylphenethylamine), its salts, optical isomers, | ||
| and salts of optical isomers. | ||
| SECTION 2. This Act takes effect September 1, 2011. | ||
